Table 1.

Patient demographics and relative genetic contribution (r_GC) to nevirapine AUC_0–6h

		European Americans	African Americans
Sample Size	n	11	6
Gender	Male (%)	4 (36)	1 (17)
	Female (%)	7 (64)	5 (83)
Age (years)	Median	45	49
	Range	29 – 57	33 – 74
Nevirapine AUC0–6h (mg/L*hr)1	SDw2	2.39	5.34
	SDb2	24.9	54.7
Estimated Relative Genetic Component	rGC2 (95% CI)	0.904 (0.64 – 0.97)	0.902 (0.42 – 0.98)
	F	10.4	10.2
	p	0.02	0.01

¹SD_w² is within individual variation and SD_b² is within subjects variation.

²Estimated relative genetic component